Myo4, a First-in-Class Anti-obesogenic and Muscle Preserving Small Molecule Metabolic Modulator

Back to All Posts
  • Publication

American Diabetes Association’s 2025 Scientific Sessions – Diabetes (2025) 74 (Supplement1) Abstract 1992-LB. Holder J et al ‘Myo4, a First-in-Class Anti-obesogenic and Muscle Preserving Small Molecule Metabolic Modulator’

Read publication: https://doi.org/10.2337/db25-1992-LB